VITAFOXO logo

VITAFOXO
VitaFOXO

0
Mkt Cap
$0.00
24H Volume
$25,945.00
FDV
$523,629.00
Circ Supply
0.00
Total Supply
10M
VITAFOXO Fundamentals
Max Supply
10M
7D High
$0.0597
7D Low
$0.0496
24H High
$0.0538
24H Low
$0.0522
All-Time High
$0.0606
All-Time Low
$0.0496
VITAFOXO Prices
VITAFOXO / USD
$0.0523
VITAFOXO / EUR
€0.0449
VITAFOXO / GBP
£0.0392
VITAFOXO / CAD
CA$0.0731
VITAFOXO / AUD
A$0.0792
VITAFOXO / INR
₹4.70
VITAFOXO / NGN
NGN 75.76
VITAFOXO / NZD
NZ$0.0908
VITAFOXO / PHP
₱3.09
VITAFOXO / SGD
SGD 0.0678
VITAFOXO / ZAR
ZAR 0.8882
Loading...
Loading...
News
all
press releases

Sentiment

Indicates whether most users posting on a symbol’s stream over the last 24 hours are fearful or greedy.
0
25
50
75
100
Extreme
Fear
Neutral
Greed
Extreme
Fear
Greed
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Message Volume

Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Participation Ratio

Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

AboutThis project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan. Dr. Lorna Harries’ lab has identified an innovative way to modulate FOXO3, a well known and yet undrugged longevity target, and propose leveraging it to address chronic lower back pain stemming from degenerative disc disease. They plan to make short, lab-made modified RNA molecules (antisense oligonucleotides) that selectively switch FOXO3’s “good” message on, first in human cells and mini-disc models. Success would yield 1) a lead drug candidate, 2) proof it can restore disc health, and 3) the data needed for patenting and further development. The same molecules could later be adapted to treat many other age-related conditions, helping people stay healthy for longer.
Details
Links
Source
Categories
Base EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
December 04, 2025
$0.00
$25,944.59
---
December 04, 2025
$0.00
$26,703.75
---
December 03, 2025
$0.00
$32,475.42
$0.0547
December 02, 2025
$0.00
$28,367.15
$0.0519
December 01, 2025
$0.00
$37,836.49
$0.0563
November 30, 2025
$0.00
$47,359.88
$0.0575
November 29, 2025
$0.00
$47,359.88
$0.0575

Latest VITAFOXO News

No VITAFOXO.X news at the moment.

Advertisement|Remove ads.